A Comparative Randomized Trial of Low-Dose Versus High-Dose Streptokinase in Deep Vein Thrombosis of the Thigh

Summary

Fibrinolytic treatment of acute deep vein thrombosis (DVT) of the leg with high-dose streptokinase (SK) (100,000 U/h) in 39 cases, or low-dose SK (approx 10,000 U/h) in combination with low-dose heparin in 41 cases, was studied in a prospective randomized trial. The degree of thrombolysis was similar in both groups and did not correlate with age or size of the thrombus or with fibrinogen level. The degree of late recanalization was also similar in both groups. There were however significantly more patients with postthrombotic changes in the low-dose group than in the high-dose group after a mean follow-up time of 31 and 38 months respectively. In the low-dose group 2 intracranial hemorrhages occurred (one was fatal) and one patient died of pulmonary embolism, but there were significantly less allergic side effects to SK. There were no cases of such serious side effects in the highdose group. Although low-dose SK has equal thrombolytic effect it seems inferior to high-dose SK, since it probably causes more severe hemorrhagic side-effects.

Keywords

Deep venous thrombosis - Streptokinase treatment - Low-dose-thrombolysis - Follow-up

• References

• 1 Kakkar VV. Fibrinolytic treatment of venous thrombosis. Thrombos Diathes Haemorrh 1974; suppl 59: 227-237
• 2 Verstraete M, Vermylen J, Amery A, Vermylen C. Thrombolytic therapy with streptokinase using a standard dosage scheme. Br Med J 1966; 1: 454-456
• 3 Cade JF, Hirsh J, Regoeczi E, Gent M, Buchanan MR, Hynes DM. Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens. J Clin Invest 1974; 54: 782-791
• 4 Collen D, Verstraete M. Alpha-2-antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy. Thromb Res 1979; 14: 631-639
• 5 Johnson AJ, McCarthy WR. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. J Clin Invest 1959; 38: 1627-1643
• 6 Gallus AS, Hirsh J, Cade JF, Turpie AG, Walker IR, Gent M. Thrombolysis with a combination of small doses of streptokinase and full doses of heparin. Semin Thromb Hemostas 1975; 2: 14-32
• 7 Nyman D, Biland L, Rust O, Duckert F, daSilva M, Madar G, Widmer LK, Schmitt HE. Die thrombolytische Behandlung der tiefen Venenthrombose mit geringen Streptokinase-Dosen: Minilyse. In Aktuelle Probleme in der Angiologie (Lecture, Angiol. Conf. Vienna 1975.). Ehringer H. (Ed.) Publ Hans Huber; Bern - Stuttgart - Vienna: 1977. 33 133-136
• 8 NIH Consensus Development Conference Summary: Thrombolytic therapy in thrombosis 1980. Stroke. 1981 12. 17-21
• 9 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144
• 10 Marder VJ, Soulen RL, Atichartakam V, Budzynski AZ, Parulekar S, Kim JR, Edward N, Zahavi J, Algazy KM. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 1977; 89: 1018-1029
• 11 May R, Nissl R. Die Phlebographie der unteren Extremität. Georg Thieme Verlag; Stuttgart: 1959. p 83
• 12 Vermylen C, de Vreker RA, Verstraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT-test). Clin Chim Acta 1963; 8: 418-424
• 13 Marder VJ. Guidelines for thrombolytic therapy of deep-vein thrombosis. Prog Cardiovasc Dis 1979; 21: 327-332
• 14 Duckert F, Marbet GA, Walter M, Six P, Nyman D, Madar G, daSilva MA, Widmer LK, Schmitt HE, Vokal J. Thrombolytic treatment with a streptokinase low dose regimen. In New concepts in streptokinase therapy. Martin M, Schoop W. Hirsh. (eds) Hans Huber Publisher; Bern - Stuttgart - Vienna: 1978. pp 83-86
• 15 Genton E. Thrombolytic therapy of pulmonary embolism. Prog Cardiovasc Dis 1979; 21: 333-341
• 16 Conard J, Samama M. Laboratory control of SK therapy. In Present status of thrombosis. Its pathophysiology, diagnosis and treatment. Losito R. (ed) pp 191-198 Schattauer; Stuttgart: 1973
• 17 Duckert F, Benz A, Prisender S, daSilva MA, Schmitt HE. Coagulation parameters and success of thrombolytic treatment in deep vein thrombosis. Vasa 1974; 3: 138-139
• 18 Kakkar VV. Intermittent plasminogen streptokinase treatment of deep vein thrombosis. In progress in fibrinolysis. Davidson J, Nilsson IM, Samama M. (eds) Churchill Livingstone; 1981: 420-431
• 19 Marbet GA, Eichlisberger R, Duckert F, daSilva MA, Biland L, Widmer LK, Ritz R, Schmitt HE. Sequential treatment of deep leg vein thrombosis with porcine plasmin and low dose streptokinase. Thromb Haemostas 1982; 48: 190-195
• 20 Elliot MS, Immelman EJ, Jeffery P, Benatar SR, Funston MR, Smith JA, Shepstone BJ, Ferguson AD, Jacobs P, Walker W, Louw JH. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 1979; 66: 838-843
• 21 Albrechtsson U, Anderson J, Einarsson E, Eklöf B, Norgren L. Streptokinase treatment of deep venous thrombosis and the postthrombotic syndrome. Arch Surg 1981; 116: 33-37
• 22 Amesen H, Høiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982; 211: 65-68
• 23 Markus G, Werkheiser WC. The interaction of streptokinase with plasminogen. J Biol Chem 1964; 239: 2637-43
• 24 Markus G, Ambrus CM. On the formation of different types of plasmin by streptokinase activation. J Biol Chem 1960; 235: 1673-1679